---
title: "Other cancer"
output:
    html_document:
        theme: null
        template: null
        self_contained: false
        pandoc_args: ["--no-highlight"]
bibliography: references.bib
link-citations: true
---


<style type="text/css">

body{
    background:#F0F0F0;}
details{
    background:#e1f9fa;}

</style>
_[auto-generated file]_

Other cancer is a **death cause**. It means that there is a certain probability that one dies from this.

#### Alternative names:
* Other cancer
* OtherCancer

#### Categories

Other cancer is part of the following death cause categories

* [Cancer](/model/Cancer)

#### Risk factors

Other cancer has no [risk factors](/model/intro#risk-factor) in the model (yet).

#### Number of deaths

In 2014 Other cancer was responsible for 3.99% of the deaths in the US. Below is a plot of how prevalent the death was for different ages [@CDCreport]
```{r echo=FALSE, message=FALSE, warning=FALSE, paged.print=FALSE}
library(devtools)
devtools::load_all('../../../Reportgeneration/DatabaseVisualization/RRtablePlotting')
dat=initialize_database(c("../../../death-causes-app/src/resources/Causes.json"),
"../../../death-causes-app/src/resources/Descriptions.json")
```

```{r echo=FALSE, message=FALSE, warning=FALSE, paged.print=FALSE}
plotSpecificPlots(dat, 'OtherCancer')
```


#### Definition

The definition of dying from Other cancer is to get any of the following ICD codes as the main cause of death on one's death certificate. The percentage is the proportion of the deaths from Other cancer who falls under the ICD code 

* <details><summary> C17: Malignant neoplasm of small intestine (1.3%)</summary>
    * C170: Malignant neoplasm of duodenum (0.7%)
    * C171: Malignant neoplasm of jejunum (0.05%)
    * C172: Malignant neoplasm of ileum (0.049%)
    * C179: Malignant neoplasm of small intestine, unspecified (0.49%)
</details>
* C23: Malignant neoplasm of gallbladder (2.2%)
* <details><summary> C24: Malignant neoplasm of other and unspecified parts of biliary tract (1.5%)</summary>
    * C240: Malignant neoplasm of extrahepatic bile duct (0.61%)
    * C241: Malignant neoplasm of ampulla of Vater (0.15%)
    * C248: Malignant neoplasm of overlapping sites of biliary tract (0.0067%)
    * C249: Malignant neoplasm of biliary tract, unspecified (0.75%)
</details>
* <details><summary> C26: 0 Malignant neoplasm of other and ill-defined digestive organs Malignant neoplasm of other and ill-defined digestive organs (1.6%)</summary>
    * C260: Malignant neoplasm of intestinal tract, part unspecified (0.32%)
    * C261: Malignant neoplasm of spleen (0.027%)
    * C269: 1 Malignant neoplasm of ill-defined sites within the dgstv sys Malignant neoplasm of ill-defined sites within the digestive system (1.2%)
</details>
* <details><summary> C30: Malignant neoplasm of nasal cavity and middle ear (0.074%)</summary>
    * C300: Malignant neoplasm of nasal cavity (0.073%)
    * C301: Malignant neoplasm of middle ear (0.00095%)
</details>
* <details><summary> C31: Malignant neoplasm of accessory sinuses (0.38%)</summary>
    * C310: Malignant neoplasm of maxillary sinus (0.16%)
    * C311: Malignant neoplasm of ethmoidal sinus (0.018%)
    * C312: Malignant neoplasm of frontal sinus (0.0019%)
    * C313: Malignant neoplasm of sphenoid sinus (0.011%)
    * C319: Malignant neoplasm of accessory sinus, unspecified (0.2%)
</details>
* C37: Malignant neoplasm of thymus (0.28%)
* <details><summary> C38: Malignant neoplasm of heart, mediastinum and pleura (0.26%)</summary>
    * C380: Malignant neoplasm of heart (0.067%)
    * C383: Malignant neoplasm of mediastinum, part unspecified (0.095%)
    * C384: Malignant neoplasm of pleura (0.1%)
</details>
* <details><summary> C39: 0 Malig neoplm of sites in the resp sys and intrathorac organs Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs (0.06%)</summary>
    * C399: Malignant neoplasm of lower respiratory tract, part unspecified (0.06%)
</details>
* <details><summary> C40: Malignant neoplasm of bone and articular cartilage of limbs (0.072%)</summary>
    * C400: Malignant neoplasm of scapula and long bones of upper limb (0.013%)
    * C401: Malignant neoplasm of short bones of upper limb (0.00095%)
    * C402: Malignant neoplasm of long bones of lower limb (0.056%)
    * C403: Malignant neoplasm of short bones of lower limb (0.00095%)
    * C409: 0 Malignant neoplasm of unsp bones and artic cartilage of limb Malignant neoplasm of unspecified bones and articular cartilage of limb (0.00095%)
</details>
* <details><summary> C41: Malignant neoplasm of bone and articular cartilage of other and unspecified sites (1.4%)</summary>
    * C410: Malignant neoplasm of bones of skull and face (0.043%)
    * C411: Malignant neoplasm of mandible (0.1%)
    * C412: Malignant neoplasm of vertebral column (0.075%)
    * C413: Malignant neoplasm of ribs, sternum and clavicle (0.016%)
    * C414: Malignant neoplasm of pelvic bones, sacrum and coccyx (0.05%)
    * **C419: Malignant neoplasm of bone and articular cartilage, unspecified (1.1%)**
</details>
* <details><summary> C44: Other and unspecified malignant neoplasm of skin (3.6%)</summary>
    * C440: Other and unspecified malignant neoplasm of skin of lip (0.0076%)
    * C441: Other and unspecified malignant neoplasm of skin of eyelid, including canthus (0.0086%)
    * C442: Other and unspecified malignant neoplasm of skin of ear and external auricular canal (0.11%)
    * C443: 0 Oth and unsp malignant neoplasm skin/ and unsp parts of face Other and unspecified malignant neoplasm of skin of other and unspecified parts of face (0.28%)
    * **C444: Other and unspecified malignant neoplasm of skin of scalp and neck (1.3%)**
    * C445: Other and unspecified malignant neoplasm of skin of trunk (0.053%)
    * C446: Other and unspecified malignant neoplasm of skin of upper limb, including shoulder (0.042%)
    * C447: Other and unspecified malignant neoplasm of skin of lower limb, including hip (0.046%)
    * C448: 0 Oth and unsp malignant neoplasm of overlapping sites of skin Other and unspecified malignant neoplasm of overlapping sites of skin (0.00095%)
    * **C449: Other and unspecified malignant neoplasm of skin, unspecified (1.7%)**
</details>
* <details><summary> C45: Mesothelioma (2.5%)</summary>
    * C450: Mesothelioma of pleura (0.18%)
    * C451: Mesothelioma of peritoneum (0.12%)
    * C452: Mesothelioma of pericardium (0.0076%)
    * C457: Mesothelioma of other sites (0.22%)
    * **C459: Mesothelioma, unspecified (1.9%)**
</details>
* <details><summary> C46: Kaposi's sarcoma (0.055%)</summary>
    * C460: Kaposi's sarcoma of skin (0.0019%)
    * C467: Kaposi's sarcoma of other sites (0.0048%)
    * C469: Kaposi's sarcoma, unspecified (0.049%)
</details>
* <details><summary> C47: Malignant neoplasm of peripheral nerves and autonomic nervous system (0.07%)</summary>
    * C470: Malignant neoplasm of peripheral nerves of head, face and neck (0.00095%)
    * C471: Malignant neoplasm of peripheral nerves of upper limb, including shoulder (0.0019%)
    * C472: Malignant neoplasm of peripheral nerves of lower limb, including hip (0.00095%)
    * C475: Malignant neoplasm of peripheral nerves of pelvis (0.0019%)
    * C479: Malignant neoplasm of peripheral nerves and autonomic nervous system, unspecified (0.064%)
</details>
* <details><summary> C48: Malignant neoplasm of retroperitoneum and peritoneum (0.99%)</summary>
    * C480: Malignant neoplasm of retroperitoneum (0.23%)
    * C481: Malignant neoplasm of specified parts of peritoneum (0.05%)
    * C482: Malignant neoplasm of peritoneum, unspecified (0.71%)
</details>
* <details><summary> C49: Malignant neoplasm of other connective and soft tissue (4.4%)</summary>
    * C490: Malignant neoplasm of connective and soft tissue of head, face and neck (0.1%)
    * C491: Malignant neoplasm of connective and soft tissue of upper limb, including shoulder (0.053%)
    * C492: Malignant neoplasm of connective and soft tissue of lower limb, including hip (0.24%)
    * C493: Malignant neoplasm of connective and soft tissue of thorax (0.081%)
    * C494: Malignant neoplasm of connective and soft tissue of abdomen (0.31%)
    * C495: Malignant neoplasm of connective and soft tissue of pelvis (0.13%)
    * C496: Malignant neoplasm of connective and soft tissue of trunk, unspecified (0.01%)
    * **C499: Malignant neoplasm of connective and soft tissue, unspecified (3.5%)**
</details>
* <details><summary> C51: Malignant neoplasm of vulva (1.0%)</summary>
    * C510: Malignant neoplasm of labium majus (0.015%)
    * C512: Malignant neoplasm of clitoris (0.0029%)
    * C519: Malignant neoplasm of vulva, unspecified (1.0%)
</details>
* C52: Malignant neoplasm of vagina (0.41%)
* <details><summary> C57: Malignant neoplasm of other and unspecified female genital organs (0.62%)</summary>
    * C570: Malignant neoplasm of fallopian tube (0.31%)
    * C574: Malignant neoplasm of uterine adnexa, unspecified (0.012%)
    * C577: Malignant neoplasm of other specified female genital organs (0.017%)
    * C578: Malignant neoplasm of overlapping sites of female genital organs (0.0019%)
    * C579: Malignant neoplasm of female genital organ, unspecified (0.28%)
</details>
* C58: Malignant neoplasm of placenta (0.012%)
* <details><summary> C60: Malignant neoplasm of penis (0.29%)</summary>
    * C601: Malignant neoplasm of glans penis (0.0038%)
    * C602: Malignant neoplasm of body of penis (0.00095%)
    * C609: Malignant neoplasm of penis, unspecified (0.29%)
</details>
* <details><summary> C62: Malignant neoplasm of testis (0.39%)</summary>
    * C629: Malignant neoplasm of testis, unspecified whether descended or undescended (0.39%)
</details>
* <details><summary> C63: Malignant neoplasm of other and unspecified male genital organs (0.068%)</summary>
    * C630: Malignant neoplasm of epididymis (0.00095%)
    * C631: Malignant neoplasm of spermatic cord (0.0029%)
    * C632: Malignant neoplasm of scrotum (0.02%)
    * C637: Malignant neoplasm of other specified male genital organs (0.00095%)
    * C639: Malignant neoplasm of male genital organ, unspecified (0.043%)
</details>
* C66: Malignant neoplasm of ureter (0.38%)
* <details><summary> C68: Malignant neoplasm of other and unspecified urinary organs (0.41%)</summary>
    * C680: Malignant neoplasm of urethra (0.21%)
    * C689: Malignant neoplasm of urinary organ, unspecified (0.2%)
</details>
* <details><summary> C69: Malignant neoplasm of eye and adnexa (0.31%)</summary>
    * C691: Malignant neoplasm of cornea (0.0019%)
    * C692: Malignant neoplasm of retina (0.014%)
    * C693: Malignant neoplasm of choroid (0.041%)
    * C694: Malignant neoplasm of ciliary body (0.022%)
    * C695: Malignant neoplasm of lacrimal gland and duct (0.011%)
    * C696: Malignant neoplasm of orbit (0.033%)
    * C699: Malignant neoplasm of unspecified site of eye (0.19%)
</details>
* C73: Malignant neoplasm of thyroid gland (1.7%)
* <details><summary> C74: Malignant neoplasm of adrenal gland (0.57%)</summary>
    * C740: Malignant neoplasm of cortex of adrenal gland (0.093%)
    * C741: Malignant neoplasm of medulla of adrenal gland (0.033%)
    * C749: Malignant neoplasm of unspecified part of adrenal gland (0.45%)
</details>
* <details><summary> C75: Malignant neoplasm of other endocrine glands and related structures (0.15%)</summary>
    * C750: Malignant neoplasm of parathyroid gland (0.016%)
    * C751: Malignant neoplasm of pituitary gland (0.029%)
    * C752: Malignant neoplasm of craniopharyngeal duct (0.00095%)
    * C753: Malignant neoplasm of pineal gland (0.027%)
    * C754: Malignant neoplasm of carotid body (0.0019%)
    * C755: Malignant neoplasm of aortic body and other paraganglia (0.02%)
    * C759: Malignant neoplasm of endocrine gland, unspecified (0.058%)
</details>
* <details><summary> C76: Malignant neoplasm of other and ill-defined sites (1.6%)</summary>
    * C760: Malignant neoplasm of head, face and neck (0.5%)
    * C761: Malignant neoplasm of thorax (0.069%)
    * C762: Malignant neoplasm of abdomen (0.62%)
    * C763: Malignant neoplasm of pelvis (0.21%)
    * C764: Malignant neoplasm of upper limb (0.0076%)
    * C765: Malignant neoplasm of lower limb (0.024%)
    * C767 (0.15%)
    * C768: Malignant neoplasm of other specified ill-defined sites (0.0029%)
</details>
* <details><summary> C77: Secondary and unspecified malignant neoplasm of lymph nodes (0.047%)</summary>
    * C770: Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck (0.0076%)
    * C771: Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes (0.0019%)
    * C772: Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes (0.0038%)
    * C773: Secondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes (0.00095%)
    * C774: 1 Sec and unsp malig neoplasm of inguinal and lower limb nodes Secondary and unspecified malignant neoplasm of inguinal and lower limb lymph nodes (0.00095%)
    * C779: Secondary and unspecified malignant neoplasm of lymph node, unspecified (0.031%)
</details>
* <details><summary> C78: Secondary malignant neoplasm of respiratory and digestive organs (3.1%)</summary>
    * C780: Secondary malignant neoplasm of lung (0.23%)
    * C781: Secondary malignant neoplasm of mediastinum (0.012%)
    * C782: Secondary malignant neoplasm of pleura (0.2%)
    * C783: Secondary malignant neoplasm of other and unspecified respiratory organs (0.00095%)
    * C784: Secondary malignant neoplasm of small intestine (0.00095%)
    * C785: Secondary malignant neoplasm of large intestine and rectum (0.042%)
    * C786: Secondary malignant neoplasm of retroperitoneum and peritoneum (0.61%)
    * **C787: 1 Secondary malig neoplasm of liver and intrahepatic bile duct Secondary malignant neoplasm of liver and intrahepatic bile duct (2.0%)**
    * C788: Secondary malignant neoplasm of other and unspecified digestive organs (0.039%)
</details>
* <details><summary> C79: Secondary malignant neoplasm of other and unspecified sites (4.3%)</summary>
    * C790: Secondary malignant neoplasm of kidney and renal pelvis (0.0067%)
    * C791: Secondary malignant neoplasm of bladder and other and unspecified urinary organs (0.0086%)
    * C792: Secondary malignant neoplasm of skin (0.0095%)
    * C793: Secondary malignant neoplasm of brain and cerebral meninges (0.63%)
    * C794: Secondary malignant neoplasm of other and unspecified parts of nervous system (0.0076%)
    * C795: Secondary malignant neoplasm of bone and bone marrow (0.43%)
    * C796: Secondary malignant neoplasm of ovary (0.0048%)
    * C797: Secondary malignant neoplasm of adrenal gland (0.0029%)
    * **C798: Secondary malignant neoplasm of other specified sites (3.2%)**
</details>
* **C80: Malignant neoplasm without specification of site (25.0%)**
* <details><summary> C88: Malignant immunoproliferative diseases and certain other B-cell lymphomas (0.28%)</summary>
    * C880: Waldenstrom macroglobulinemia (0.28%)
    * C882: Heavy chain disease (0.0019%)
    * C889: Malignant immunoproliferative disease, unspecified (0.00095%)
</details>
* <details><summary> **C9 (38.0%)**</summary>
    * **C90: Multiple myeloma and malignant plasma cell neoplasms (12.0%)**
        * C900: Multiple myeloma (11.0%)
        * C901: Plasma cell leukemia (0.11%)
        * C902: Extramedullary plasmacytoma (0.095%)
    * **C91: Lymphoid leukemia (6.2%)**
        * **C910: Acute lymphoblastic leukemia [ALL] (1.4%)**
        * **C911: Chronic lymphocytic leukemia of B-cell type (4.3%)**
        * C913: Prolymphocytic leukemia of B-cell type (0.032%)
        * C914: Hairy cell leukemia (0.11%)
        * C915: Adult T-cell lymphoma/leukemia (HTLV-1-associated) (0.098%)
        * C917 (0.04%)
        * C919: Lymphoid leukemia, unspecified (0.2%)
    * **C92: Myeloid leukemia (11.0%)**
        * **C920: Acute myeloblastic leukemia (9.3%)**
        * C921: Chronic myeloid leukemia, BCR/ABL-positive (1.1%)
        * C922: Atypical chronic myeloid leukemia, BCR/ABL-negative (0.00095%)
        * C923: Myeloid sarcoma (0.044%)
        * C924: Acute promyelocytic leukemia (0.13%)
        * C925: Acute myelomonocytic leukemia (0.13%)
        * C927 (0.46%)
        * C929: Myeloid leukemia, unspecified (0.26%)
    * C93: Monocytic leukemia (0.11%)
        * C930: Acute monoblastic/monocytic leukemia (0.088%)
        * C931: Chronic myelomonocytic leukemia (0.015%)
        * C937 (0.00095%)
        * C939: Monocytic leukemia, unspecified (0.0057%)
    * C94: Other leukemias of specified cell type (0.069%)
        * C940: Acute erythroid leukemia (0.014%)
        * C941 (0.00095%)
        * C942: Acute megakaryoblastic leukemia (0.0048%)
        * C945 (0.0029%)
        * C947 (0.046%)
    * **C95: Leukemia of unspecified cell type (4.6%)**
        * C950: Acute leukemia of unspecified cell type (1.6%)
        * C951: Chronic leukemia of unspecified cell type (0.17%)
        * C957 (0.0067%)
        * C959: Leukemia, unspecified (2.8%)
    * C96: 0 Oth & unsp malig neoplm of lymphoid, hematpoetc and rel tiss Other and unspecified malignant neoplasms of lymphoid, hematopoietic and related tissue (0.091%)
        * C961 (0.0086%)
        * C962: Malignant mast cell tumor (0.01%)
        * C967 (0.0086%)
        * C969: Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified (0.063%)
    * **C97 (4.3%)**
</details>

 Source: @CDCreport, @ICDcodes



## References